Literature DB >> 8642844

Clinical significance of LEA-1 expression in adult acute myeloid leukemia.

H Kawada1, R Fukuda, M Yoshida, M Takei, N Kobayashi, A Masumoto, Y Ogawa, T Sasao, N Kubota, S Watanabe, Y Umeda, K Yamauchi, S Yonekura, Y Ichikawa.   

Abstract

In this study, we examined expressions of several adhesion molecules (AdMs), i.e. leukocyte function antigen-1 (LFA-1: CD11a/CD18), Hermes homing receptor (CD44) and intercellular adhesion molecule-1 (ICAM-1: CD54), on leukemia cells from 51 adult patients with newly diagnosed acute myeloid leukemias (AMLs) to elucidate clinical significance of these AdM expressions. Those expressions in lymphoid malignancies have been correlated with tumor evolutions, but CD44 was detected in all the AML cases examined and CD54 expression did not associate with their clinical characteristics or outcomes. However, we found that LFA-1 expressions significantly correlated with splenomegaly, resistance to induction chemotherapies and short survival periods in AML patients.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8642844     DOI: 10.1016/0145-2126(95)00113-1

Source DB:  PubMed          Journal:  Leuk Res        ISSN: 0145-2126            Impact factor:   3.156


  2 in total

1.  Adhesion molecules in acute myeloid leukemia.

Authors:  E Paietta
Journal:  Leuk Res       Date:  1996-09       Impact factor: 3.156

2.  TGF-β1 potentiates Vγ9Vδ2 T cell adoptive immunotherapy of cancer.

Authors:  Richard E Beatson; Ana C Parente-Pereira; Leena Halim; Domenico Cozzetto; Caroline Hull; Lynsey M Whilding; Olivier Martinez; Chelsea A Taylor; Jana Obajdin; Kim Ngan Luu Hoang; Benjamin Draper; Ayesha Iqbal; Tom Hardiman; Tomasz Zabinski; Francis Man; Rafael T M de Rosales; Jinger Xie; Fred Aswad; Daniela Achkova; Chung-Yang Ricardo Joseph; Sara Ciprut; Antonella Adami; Helge G Roider; Holger Hess-Stumpp; Balázs Győrffy; Jelmar Quist; Anita Grigoriadis; Anette Sommer; Andrew N J Tutt; David M Davies; John Maher
Journal:  Cell Rep Med       Date:  2021-12-21
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.